Type D personality, self-efficacy, and medication adherence in patients with heart failure-A mediation analysis

Heart and Lung

Volumn 44, Issue 4, 2015, Pages 276-281

  Wu, Jia Rong ^a   Song, Eun Kyeung ^b   Moser, Debra K ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

Heart failure; Medication adherence; Medication self efficacy; Type D personality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AFFECT; ARTICLE; COMORBIDITY; FEMALE; HEALTH BEHAVIOR; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NEGATIVE AFFECTIVITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF CARE; SELF CONCEPT; SENSITIVITY ANALYSIS; SOCIAL BEHAVIOR; SOCIAL INHIBITION; TYPE D BEHAVIOR; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; INTERPERSONAL COMMUNICATION; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

ADULT; COUNSELING; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEGOTIATING; PATIENT EDUCATION AS TOPIC; SELF EFFICACY; TYPE D PERSONALITY;

EID: 84930822260     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2015.03.006     Document Type: Article

References (56)

1. Denollet J., Sys S.U., Stroobant N., Rombouts H., Gillebert T.C., Brutsaert D.L. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996, 347(8999):417-421.
2. Denollet J., Sys S.U., Brutsaert D.L. Personality and mortality after myocardial infarction. Psychosom Med 1995, 57(6):582-591.
3. Pedersen S.S., Herrmann-Lingen C., de Jonge P., Scherer M. Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class. JBehav Med 2010, 33(1):72-80.
4. Schiffer A.A., Pedersen S.S., Widdershoven J.W., Denollet J. Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure. Eur J Heart Fail 2008, 10(9):922-930.
5. Schiffer A.A., Pedersen S.S., Widdershoven J.W., Hendriks E.H., Winter J.B., Denollet J. The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005, 12(4):341-346.
6. Denollet J., Brutsaert D.L. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998, 97(2):167-173.
7. Denollet J., Vaes J., Brutsaert D.L. Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000, 102(6):630-635.
8. Martens E.J., Mols F., Burg M.M., Denollet J. Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. JClin Psychiatry 2010, 71(6):778-783.
9. Michal M., Wiltink J., Grande G., Beutel M.E., Brahler E. Type D personality is independently associated with major psychosocial stressors and increased health care utilization in the general population. JAffect Disord 2011, 134(1-3):396-403.
10. Aquarius A.E., Smolderen K.G., Hamming J.F., De Vries J., Vriens P.W., Denollet J. Type D personality and mortality in peripheral arterial disease: a pilot study. Arch Surg 2009, 144(8):728-733.
11. Pedersen S.S., van den Broek K.C., Erdman R.A., Jordaens L., Theuns D.A. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010, 12(10):1446-1452.
12. Schiffer A.A., Smith O.R., Pedersen S.S., Widdershoven J.W., Denollet J. Type D personality and cardiac mortality in patients with chronic heart failure. Int J Cardiol 2010, 142(3):230-235.
13. Kupper N., Denollet J. Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms. JPers Assess 2007, 89(3):265-276.
14. Mols F., Denollet J. Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes 2010, 8:9.
15. Brostrom A., Stromberg A., Martensson J., Ulander M., Harder L., Svanborg E. Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. JSleep Res 2007, 16(4):439-447.
16. Dieltjens M., Vanderveken O.M., Van den Bosch D., et al. Impact of type D personality on adherence to oral appliance therapy for sleep-disordered breathing. Sleep Breath 2013 Sep, 17(3):985-991.
17. Wu J.R., Moser D.K., Lennie T.A., Burkhart P.V. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am 2008, 43(1):133-153.
18. Li H., Morrow-Howell N., Proctor E.K. Post-acute home care and hospital readmission of elderly patients with congestive heart failure. Health Soc Work 2004, 29(4):275-285.
19. Chui M.A., Deer M., Bennett S.J., et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 2003, 23(3):326-332.
20. Hope C.J., Wu J., Tu W., Young J., Murray M.D. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004, 61(19):2043-2049.
21. Molloy G.J., Randall G., Wikman A., Perkins-Porras L., Messerli-Burgy N., Steptoe A. Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome. Psychosom Med 2012, 74(1):100-106.
22. Williams L., O'Connor R.C., Grubb N., O'Carroll R. Type D personality predicts poor medication adherence in myocardial infarction patients. Psychol Health 2011, 1-10.
23. van de Ven M.O., Witteman C.L., Tiggelman D. Effect of Type D personality on medication adherence in early adolescents with asthma. JPsychosom Res 2013, 75(6):572-576.
24. Wu J.R., Moser D.K. Type D personality predicts poor medication adherence in patients with heart failure in the USA. Int J Behav Med 2014, 21(5):833-842.
25. Glanz K., Rimer B.K., Viswanath K. Health Behavior and Health Education: Theory Research and Practice 2008, Jossey-Bass, San Francisco. 4th ed.
26. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977, 84(2):191-215.
27. Schoenthaler A., Ogedegbe G., Allegrante J.P. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 2009, 36(1):127-137.
28. Risser J., Jacobson T.A., Kripalani S. Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. JNurs Meas 2007, 15(3):203-219.
29. Wolf M.S., Davis T.C., Osborn C.Y., Skripkauskas S., Bennett C.L., Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns 2007, 65(2):253-260.
30. Reynolds N.R., Testa M.A., Marc L.G., et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav 2004, 8(2):141-150.
31. Johnson M.O., Chesney M.A., Goldstein R.B., et al. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: a mediation model. AIDS Patient Care STDS 2006, 20(4):258-268.
32. Chesney M.A., Ickovics J.R., Chambers D.B., et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000, 12(3):255-266.
33. Kobau R., DiIorio C. Epilepsy self-management: a comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviors among people with epilepsy. Epilepsy Behav 2003, 4(3):217-225.
34. Sacco W.P., Wells K.J., Vaughan C.A., Friedman A., Perez S., Matthew R. Depression in adults with type 2 diabetes: the role of adherence, body mass index, and self-efficacy. Health Psychol 2005, 24(6):630-634.
35. Wu J.R., Corley D.J., Lennie T.A., Moser D.K. Effect of a medication-taking behavior feedback theory-based intervention on outcomes in patients with heart failure. JCard Fail 2012, 18(1):1-9.
36. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005, 67(1):89-97.
37. Kupper N., Gidron Y., Winter J., Denollet J. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med 2009, 71(9):973-980.
38. Evangelista L.S., Dracup K. Acloser look at compliance research in heart failure patients in the last decade. Prog Cardiovasc Nurs 2000, 15(3):97-103.
39. Haynes R.B., McDonald H.P., Garg A.X. Helping patients follow prescribed treatment: clinical applications. JAm Med Assoc 2002, 288(22):2880-2883.
40. De Geest S., Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003, 2(4):323.
41. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
42. Farrell K., Shen B.J., Mallon S., Penedo F.J., Antoni M.H. Utility of the Millon Behavioral Medicine Diagnostic to predict medication adherence in patients diagnosed with heart failure. JClin Psychol Med Settings 2011, 18(1):1-12.
43. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994, 154(4):433-437.
44. Roe C.M., Motheral B.R., Teitelbaum F., Rich M.W. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J 1999, 138(5 Pt 1):818-825.
45. Greenberg B.H., Mehra M., Teerlink J.R., Ordronneau P., McCollum D., Gilbert E.M. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. Am J Cardiol 2006, 98(7A):53L-59L.
46. Wu J.R., Moser D.K., Chung M.L., Lennie T.A. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. JCard Fail 2008, 14(7):603-614.
47. Balkrishnan R., Rajagopalan R., Camacho F.T., Huston S.A., Murray F.T., Anderson R.T. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003, 25(11):2958-2971.
48. McLane C.G., Zyzanski S.J., Flocke S.A. Factors associated with medication noncompliance in rural elderly hypertensive patients. Am J Hypertens 1995, 8(2):206-209.
49. Schiffer A.A., Denollet J., Widdershoven J.W., Hendriks E.H., Smith O.R. Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart 2007, 93(7):814-818.
50. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. JPers Soc Psychol 1986, 51(6):1173-1182.
51. Lorig K.R., Sobel D.S., Ritter P.L., Laurent D., Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract 2001, 4(6):256-262.
52. Tsay S.L. Self-efficacy training for patients with end-stage renal disease. JAdv Nurs 2003, 43(4):370-375.
53. Fu D., Fu H., McGowan P., et al. Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: randomized controlled trial. Bull World Health Organ 2003, 81(3):174-182.
54. de Voogd J.N., Wempe J.B., Postema K., et al. More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation?. Ann Behav Med 2009, 38(2):86-93.
55. Suls J., Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 2005, 131(2):260-300.
56. Wutoh A.K., Elekwachi O., Clarke-Tasker V., Daftary M., Powell N.J., Campusano G. Assessment and predictors of antiretroviral adherence in older HIV-infected patients. JAcquir Immune Defic Syndr 2003, 33(suppl 2):S106-S114.